Mereo BioPharma Group Stock (NASDAQ:MREO), Quotes and News Summary

Q: What sector and industry does Mereo BioPharma Group (MREO) operate in?

Mereo BioPharma Group is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Mereo BioPharma Group Stock (NASDAQ: MREO) stock price, news, charts, stock research, profile.

Open	$3.100
Close	$3.270
Volume / Avg.	499.616K / 1.177M
Day Range	3.040 - 3.290
52 Wk Range	0.920 - 4.360
Market Cap	$433.439M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	59
Short Interest	2.38%
Days to Cover	2.93

Recent News

Why Intel Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Shares of Intel Corporation (NASDAQ: INTC) fell sharply during Friday’s session. Intel reported upbeat results for its fourth quarter, but issued a weak forecast for the first quarter.

Avi Kapoor

Booz Allen Hamilton Posts Upbeat Results, Joins AppFolio, Gentex And Other Big Stocks Moving Higher On Friday

U.S. stocks traded mixed, with the Dow Jones gaining around 80 points on Friday.

Avi Kapoor

Why Is Mereo BioPharma Stock Trading Higher Today?

Ultragenyx Pharmaceutical Inc (NASDAQ: RARE) and Mereo BioPharma Group plc (NASDAQ: MREO) released interim data from the Phase 2 portion of the Phase 2/3 Orbit

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Mereo BioPharma Group (MREO) stock?

You can purchase shares of Mereo BioPharma Group (NASDAQ: MREO) through any online brokerage.

View our list of the best stock brokerages.

Who are Mereo BioPharma Group's (MREO) competitors?

Other companies in Mereo BioPharma Group’s space includes: Voyager Therapeutics (NASDAQ:VYGR), PepGen (NASDAQ:PEPG), Replimune Group (NASDAQ:REPL), Fate Therapeutics (NASDAQ:FATE) and Anika Therapeutics (NASDAQ:ANIK).

What is the target price for Mereo BioPharma Group (MREO) stock?

The latest price target for Mereo BioPharma Group (NASDAQ: MREO) was reported by Needham on Wednesday, April 10, 2024. The analyst firm set a price target for 6.00 expecting MREO to rise to within 12 months (a possible 94.17% upside). 9 analyst firms have reported ratings in the last year.

Current Stock Price for Mereo BioPharma Group (MREO)?

The stock price for Mereo BioPharma Group (NASDAQ: MREO) is $3.09 last updated May 8, 2024 at 7:09 PM EDT.

Does Mereo BioPharma Group (MREO) pay a dividend?

There are no upcoming dividends for Mereo BioPharma Group.

When is Mereo BioPharma Group (NASDAQ:MREO) reporting earnings?

Mereo BioPharma Group’s FY earnings are confirmed for Wednesday, March 27, 2024.

Is Mereo BioPharma Group (MREO) going to split?

There is no upcoming split for Mereo BioPharma Group.

What sector and industry does Mereo BioPharma Group (MREO) operate in?

Mereo BioPharma Group is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-